INTERCEPT PHARMACEUTICALS, INC. Consulting Agreements
8 Contracts & Agreements
- Retirement and Consulting Agreement by and between Intercept Pharmaceuticals, Inc. and Mark Pruzanski, M.D., dated December 9, 2020 (Filed With SEC on December 10, 2020)
- CONSULTING AGREEMENT (Filed With SEC on May 14, 2013)
- AMENDMENT NO. 1 TO CONSULTING AND IP AGREEMENT (Filed With SEC on April 30, 2013)
- AMENDMENT NO. 2 TO CONSULTING AND INTELLECTUAL PROPERTY(“IP”) AGREEMENT (Filed With SEC on February 22, 2013)
- CONSULTING AND INTELLECTUAL PROPERTY(“IP”) AGREEMENT (Filed With SEC on September 27, 2012)
- CONSULTING AND IP AGREEMENT (Filed With SEC on September 4, 2012)
- AMENDMENT N°1 TO CONSULTING AND INTELLECTUAL PROPERTY(“IP”) AGREEMENT (Filed With SEC on September 4, 2012)
- CONSULTING AND INTELLECTUAL PROPERTY (“IP”)AGREEMENT (Filed With SEC on September 4, 2012)
